Pacific Ethanol to Release First Quarter 2018 Results
May 02, 2018 20:05 pm UTC| Business
SACRAMENTO, Calif., May 02, 2018 -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels and high-quality alcohol products in the United States, announced it will release...
TTM Technologies, Inc. Reports Fiscal First Quarter 2018 Results
May 02, 2018 20:05 pm UTC| Business
COSTA MESA, Calif., May 02, 2018 -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (“PCB”) manufacturer, today reported results for the first quarter of fiscal 2018, which ended April 2nd,...
Ovid Therapeutics to Present at Deutsche Bank’s 43rd Annual Health Care Conference on May 9, 2018
May 02, 2018 20:05 pm UTC| Business
NEW YORK, May 02, 2018 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today announced that...
May 02, 2018 20:05 pm UTC| Business
Dosing with microRNA mimics of the microRNA-183/96/182 cluster led to functional improvement of photoreceptors and vision in retinal degeneration modelMRG-201 dosing inhibited the expression of multiple factors responsible...
MoSys to Announce First Quarter 2018 Financial Results on May 10, 2018
May 02, 2018 20:05 pm UTC| Business
SAN JOSE, Calif., May 02, 2018 -- MoSys (NASDAQ:MOSY), a provider of semiconductor solutions that enable fast, intelligent data access for cloud networking, security, test and video systems, today announced it will...
May 02, 2018 20:05 pm UTC| Business
MONACO, May 02, 2018 -- Navios Maritime Partners L.P. ("Navios Partners") (NYSE:NMM) announced today that it will host a conference call on Tuesday, May 8, 2018 at 8:30 am ET, at which time Navios Partners' senior...
TRACON to Report First Quarter 2018 Company Highlights and Financial Results on May 9, 2018
May 02, 2018 20:05 pm UTC| Business
SAN DIEGO, May 02, 2018 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related...